The profitability of Royalty Pharma plc over the past 8 years
Chart Royalty Pharma plc: operating income, net income, fiscal 2018–2025 Open the chart →Royalty Pharma plc reported net income of $770.95M in fiscal 2025, the latest fiscal year on file. That year it had operating income of $1.56B. It reported a profit in all 8 years shown. Its highest net income in these years was $2.35B, in fiscal 2019.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | $1.56B | $770.95M |
| 2024ended Dec 31, 2024 | $1.29B | $858.98M |
| 2023ended Dec 31, 2023 | $1.49B | $1.13B |
| 2022ended Dec 31, 2022 | $307.06M | $42.83M |
| 2021ended Dec 31, 2021 | $1.43B | $619.73M |
| 2020ended Dec 31, 2020 | $1.6B | $975.04M |
| 2019ended Dec 31, 2019 | $2.62B | $2.35B |
| 2018ended Dec 31, 2018 | $1.36B | $1.38B |
Fiscal years as Royalty Pharma plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Royalty Pharma plc
- The revenue of Royalty Pharma plc
- The debt of Royalty Pharma plc
- All of Royalty Pharma plc's financials, charted
Companies of a similar size
- UIUBIQUITI INC.
- ACGLARCH CAPITAL GROUP LTD.
- CBOECboe Global Markets, Inc.
- EXPEEXPEDIA GROUP, INC.
- CCLCarnival Corp Ltd.
Not investment advice. This page shows what Royalty Pharma plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.